Case Report of Novel Combination of Anthralin and Calcipotriene Leading to Trichologic Response in Alopecia Areata

The document reports on a case where a novel combination of anthralin and calcipotriene was used to treat a patient with alopecia areata (AA), an autoimmune disorder characterized by hair loss. The treatment showed a trichologic response, indicating that this combination could be a potential therapeutic option for AA, particularly in its severe forms such as alopecia totalis (AT) and alopecia universalis (AU), which are challenging to manage and cause considerable distress to patients. The summary emphasizes the importance of immunomodulation in the treatment of AA and suggests that the combination of these two agents may offer a new avenue for managing this condition.